For a drug like Bisantrene isn’t the clinical trial result the key risk or uncertainty? Once you prove that we would be expecting the BP’s lining up to court us. Race has no plan to commercialise the drug themselves based on what they have told us to date. It will be up to whichever partner/ acquirer to commercialise it, and let’s hope they do so for the sake of humanity.
Cardioprotection thread, page-853
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
0.055(3.62%) |
Mkt cap ! $268.4M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.61 | $1.56 | $106.0K | 67.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 649 | $1.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 3000 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |